Metabolism and Pharmacokinetics of [14C] BEA 2180 BR Administered Orally Compared to [14C] BEA 2180 BR Administered Intravenously in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2007

Conditions
Healthy
Interventions
DRUG

BEA 2180 BR oral

Oral solution

DRUG

BEA 2180 BR infusion

Solution for infusion to be reconstituted with isotonic saline

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY